期刊文献+

血管内皮生长因子、肿瘤坏死因子-α、CD1a、γδTCR^+ T在胸腔积液和外周血中表达及其对肺结核和肺癌的诊断价值 被引量:6

Expressions of vascular endothelial growth factor,tumor necrosis factor-α,CD1a and γδTCR^+ T in pleural effusion and peripheral blood and their diagnostic value analysis for tuberculosis and lung cancer
下载PDF
导出
摘要 目的探讨血管内皮生长因子(VEGF)、肿瘤坏死因子(TNF-α)和CD1a、γδTCR+T在胸腔积液和外周血中的表达及其对胸腔积液诊断的价值分析,以及TNF-α表达与结核性胸膜肥厚的关系。方法对36例结核性胸膜炎合并胸腔积液和34例肺癌合并胸腔积液患者,用ELISA法检测VEGF、TNF-α在胸腔积液和外周血中表达;用流式细胞仪检测CD1a、γδTCR+T在胸腔积液和外周血中阳性表达,分析TNF-α表达与结核性胸膜炎患者胸膜肥厚的关系。60例健康人的外周血作对照。结果肺癌患者胸腔积液中VEGF的含量高于结核性胸腔积液(P<0.05),而TNF-α含量却低于结核性胸腔积液(P<0.001)。结核性胸腔积液患者外周血中VEGF表达与健康人外周血中表达差异无统计学意义(P>0.05),而肺癌胸腔积液患者外周血中VEGF表达却明显高于结核患者和健康对照组,差异有统计学意义(P<0.001);结核性胸腔积液患者外周血中TNF-α表达与健康对照组、肺癌胸腔积液患者外周血比较差异有统计学意义(P<0.01)。结核性胸腔积液中TNF-α的表达与胸膜肥厚的程度呈正相关(r=0.463,P<0.01)。肺癌胸腔积液中CD1a、γδTCR+T阳性表达明显高于结核性胸腔积液(P<0.001),也高于其自身外周血中的表达(P<0.001);两组患者外周血中CD1a、γδTCR+T阳性表达与健康对照组差异无统计学意义(P>0.05)。结论VEGF、TNF-α表达及CD1a、γδTCR+T阳性表达,可作为结核性胸膜炎合并胸腔积液与肺癌并胸腔积液鉴别诊断的参考依据;结核性胸膜肥厚程度与TNF-α的表达呈正相关。 Objective To explore the expressions of vascular endothelial growth factor(VEGF),tumor necrosis factor-alpha(TNF-α),γδTCR^+ Tnd CD1a in pleural effusion and peripheral blood,and their diagnostic value analysis for tuberculosis and lung cancer,as well as the relation of TNF-α and pachynsis pleurae.Methods Thirty-six cases of tuberculous(TB)pleurisy with pleural effusion and 34 cases of lung cancer with pleural effusion were selected.The concentration of VEGF and TNF-α in the two groups pleural effusions of tuberculous and lung cancer and peripheral blood were measured by enzyme linked immunosorbent assay(ELISA).The positive expression of γδTCR^+ Tnd CD1a in pleural effusion and peripheral blood were detected by flow cytometry.To analyze the relation between TNF-α and pachynsis pleurae with tuberculous pleurisy.Peripheral 61 blood of healthy individuals were used as control.Results The concentration of VEGF in lung cancer effusion was significantly higher than that of tuberculous pleural effusion(P〈0.05),while TNF-α was significantly lower compared with tuberculous pleural effusion(P〈0.001).No statistical significance was found in the concentration of VEGF in peripheral blood between tuberculous cases and healthy individuals(P〉0.05),however,the VEGF concentration in peripheral blood was obviously higher in lung cancer cases than in the other two groups(P〈0.001).The concentration of TNF-α in tuberculous cases was higher than that of lung cancer cases and controls in peripheral blood(P〈0.01).There was a positive correlation between the concentration of TNF-α and the degree of pachynsis pleurae in tuberculous cases(r=0.463,P〈0.01).The expression of γδTCR^+ Tnd CD1a+ in lung cancer effusion was significantly higher than that of tuberculous pleural effusion(P〈0.001).The expression of γδTCR^+ Tnd CD1a^+ in lung cancer effusion was significantly higher than that of peripheral blood in lung cancer group(P〈0.001).There was no statistical significance in peripheral blood between the tuberculous,lung cancer cases and controls(P〉0.05).Conclusions The concentration of VEGF and TNF-α,the expression of γδTCR^+ Tnd CD1a^+ may be used as tools for the diagnosis of tuberculous pleurisy with pleural effusion and lung cancer with pleural effusion.The concentration of TNF-α in pleural effusion is positively correlated to the degree of residual pleural thickening in tuberculous cases.
出处 《复旦学报(医学版)》 CAS CSCD 北大核心 2008年第2期257-261,共5页 Fudan University Journal of Medical Sciences
关键词 血管内皮生长因子 肿瘤坏死因子-Α CD1A γδTCR^+T 胸腔积液 外周血 肺结核 肺癌 胸膜肥厚 vascular endothelial growth factor tumor necrosis factor-α CD1a γδTCR^+ Tleural effusion peripheral blood lung tuberculosis lung cancer pachynsis pleurae
  • 相关文献

参考文献19

  • 1Jin HY, Lee KS, Jin SM,et al. Vascular endothelial growth factor correlates with matrix metalloproteinase-9 in the pleural effusion[J]. Respir Med. 2004,98 (2) : 115 - 122.
  • 2Hada M. Report of two cases with pleural effusion and asci- tes that responded dramatically to the combination of thalido-mide, celeeoxib, irinotecan, and CDDP infused in thoracic and abdominal cavities[J]. Gan To Kagaku Ryoho. 2004,31 (4):613-617.
  • 3Hamed Ea, EI-Noweihi AM, Mohamed AZ. Vasoactive mediators (VEGF and TNF-alpha) in patients with malignant and tuberculous pleural effusions[J]. Respirology, 2004, 9 (1):81 -86.
  • 4Yeh HH, Lai WW, Chen HH, etal. Autocrine IL-6-induced Stat3 activation contributes to the pathogenesis of lung adenocarcinoma and malignant pleural effusion [J]. Oncogene, 2006,25(31) :4300 - 4309.
  • 5Kaya A, Poyraz B, Celik G, et al. Vascular endothelial growth factor in benign and malignant pleural effusions[J]. Arch Bronconeumol,2005, 41 (7) :376 - 379.
  • 6高俊珍,吕福祯.VEGF在胸膜疾病中的研究现状[J].国外医学(呼吸系统分册),2004,24(2):91-93. 被引量:3
  • 7Kalomenidis I, Kollintza A, Sigala I, et al. Angiopoietin-2 levels are elevated in exudative pleural effusions[J]. Chest, 2006, 129(5):1259- 1266.
  • 8Matsumori Y, Yano S, Goto H,et al. ZD6474, an inhibitor of vascular endothelial growth factor receptor tyrosine kinase, inhibits growth of experimental lung metastasis and production of malignant pleural effusions in a non-small cell lung cancer model[J]. Oncol Res, 2006, 16( 1 ) : 15 - 26.
  • 9Shamshiev A, Gober HJ, Donda A,et al. Presentation of the same glyeolipid by different CD1 molecules[J]. J Exp Med, 2002, 195(8):1013 -1019.
  • 10Stenger S, Niazi KR, Modli RL. Down-regulation of CD1 on antigen-pressenting cells by infection with Myeobaeterium tuberculosis[J]. J lmmunol, 1998, 161(7):3582-3588.

二级参考文献23

  • 1马晓星,杨道理,张波,徐军,武翠华.结核性和癌性胸腔积液中IL-8和NO水平测定[J].中国免疫学杂志,1997,13(2):123-123. 被引量:2
  • 2Ohta Y,Kimura K,Tamura M,et al. Biological characteristics of carcinomatosa pleuritis in 0rthotopic model systems using immune-deficient rats. Int J Oncol, 2001,18:499-505.
  • 3Yanagawa H,Takeuchi E,Suzuki Y,et al. Vascular endothelial growth factor in malignant pleural effusion associated with lung cancer. Cancer Immunol Immunother, 1999,48: 396-400.
  • 4Ohta Y,Shridhar V,Kalemkerian GP,et al. Thrombospondin-1 expression and clinical implications pleural mesothelioma.Cancer, 1999,15: 2570-2576.
  • 5Wood JM. Inhibition of vascular endothelial growth factor (VEGF) as a novel approach for cancer therapy. Medicina (B Aires), 2000,60: 41-47.
  • 6Folkman J. Tumour angiogenesis and tissur factor. Nat Med,1996,2:167-168.
  • 7Matsuyama W,Hashiguchi T,Mizoguchi A,et al. Serum levels of vascular endothelial growth factor dependent on the stage progression of lung cancer. Chest, 2000,118:948-951.
  • 8Gary LYC, Melkerneker D, Thompson PJ, et al. Transforming growth factor induces vascular endothelial growth factor elaboration from pleural mesothelial cells in vivo and in vitro.Am J Respir Crit Care Med,2002,165:88-94.
  • 9Cacciotti P,Strizzi L,Vianale G,et al. The presence of simianvirus 40 sequences in mesothelioma and mesothelial cells is associated with high levels of vascular endothelial growth factor. Am J Rispir Cell mol Biol, 2002,26: 189-193.
  • 10Yano S,Herbst RS,Shinohara H,et al. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation. Clin Cancer Res, 2000,6: 957-965.

共引文献10

同被引文献44

引证文献6

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部